Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huangshi Xiangsheng Spray is a Traditional Chinese Medicine (TCM) formulation developed for the treatment of inflammatory throat conditions. It is a liquid spray version of the established Huangshi Xiangsheng formula, which traditionally contains botanical extracts such as *Cicadae Periostracum*, *Menthae Hapalycis Herba*, and *Scutellariae Radix*. The drug is primarily indicated for acute pharyngitis and acute tonsillitis, with a specific focus on pediatric populations. It aims to alleviate symptoms such as throat pain, mucosal congestion, and hoarseness by clearing heat, resolving toxins, and soothing the pharyngeal mucosa. The product is currently undergoing Phase II clinical evaluation to assess its efficacy in shortening the course of disease and its safety profile in children.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huangshi Xiangsheng Spray.